Literature DB >> 20379636

Effective dose of sedation in transesophageal echocardiography: relation to age, body surface area and left ventricle function.

Guilherme Moreira José1, Carlos Eduardo Suaide Silva, Luiz Darcy Cortez Ferreira, Yara Prosdossini Soares de Novaes, Claudia Gianini Monaco, Manuel Adán Gil, Renata Rejane Linhares, Marcelo Sgrott Rodrigues, Antônio S S de Moraes, Juarez Ortiz.   

Abstract

BACKGROUND: Sedation with midazolam and meperidine is widely used in transesophageal echocardiography. However, no mean dose is established for each individual case.
OBJECTIVE: To correlate the mean midazolam and meperidine doses for proper sedation for transesophageal echocardiography with age range, body surface area, and left ventricular ejection fraction.
METHODS: Retrospective study comprising 1,841 patients undergoing sedation based on the Ramsay scale, with a solution containing midazolam 1.5 mg (1.5 ml), meperidine 1 mg (1 ml) and distilled water (7.5 ml). Four age groups were analyzed: G1: < 24 years; G2: 25 to 44 years; G3: 45 to 64 years; and G4: > 65 years. Body surface area was calculated using the formula {[(height x 100)0.725] x (weight(0.425)) x 0.0071}. As regards the left ventricular ejection fraction, two groups were studied: GA: < 55%; and GB: > 55%. The statistical analysis was carried out using the Kruskal-Wallis test for the correlation with age and left ventricular ejection fraction, and simple linear correlation for body surface area.
RESULTS: As regards age, the mean doses of sedation required were significantly lower in G3 and G4 (p<0.01). The analysis of left ventricular ejection fraction showed that this was significantly lower in GA (p<0.01). The linear correlation coefficient between dose of sedation and body surface area was 0.09 (null).
CONCLUSION: The mean dose of sedatives required was lower in older individuals and in those with left ventricular systolic dysfunction. No correlation with body surface area was found.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20379636     DOI: 10.1590/s0066-782x2009001200011

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  3 in total

1.  Feasibility and clinical benefit of cognitive-behavioral intervention for preparing patients for transesophageal echocardiography.

Authors:  Paulina Wejner-Mik; Maria Sobczak; Dawid Miskowiec; Katarzyna Wdowiak-Okrojek; Jaroslaw D Kasprzak; Piotr Lipiec
Journal:  Anatol J Cardiol       Date:  2015-11-26       Impact factor: 1.596

2.  Previously published drug interaction models predict loss of response for transoesophageal echocardiography sedation well but not response to oesophageal instrumentation.

Authors:  Fu-Wei Su; Chien-Kun Ting; Jing-Yang Liou; Yi-Chang Chen; Mei-Yung Tsou; Shen-Chih Wang
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

3.  [New oropharyngeal double lumen cannula for sedation for transesophageal echocardiography: case series].

Authors:  Caetano Nigro Neto; Francisco José Lucena Bezerra; Rodrigo Bellio de Mattos Barreto; Davi Costa de Souza Le Bihan; Vinicius Tadeu Nogueira da Silva do Nascimento; Ingrid Caroline Baia de Souza
Journal:  Braz J Anesthesiol       Date:  2020-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.